Global Parkinson’s Disease Treatment Market Growth (Status and Outlook) 2019-2024

Published On: September 2019 | Report ID: 193689 | Category: Pharmaceuticals and HealthcarePages: 137

According to this study, over the next five years the Parkinson’s Disease Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Parkinson’s Disease Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Parkinson’s Disease Treatment market by product type, application, key companies and key regions.

This study considers the Parkinson’s Disease Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

Oral

Transdermal

Subcutaneous

Intestinal Infusion

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Acorda Therapeutics

Orion Pharmaceuticals

Roche

Teva

Voyager Therapeutics

Prothena

AbbVie

Impax Pharmaceuticals

MSD

UCB

GSK

Intec Pharma

Acadia

Adamas Therapeutics

Sunovion

NeuroDerm

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Parkinson’s Disease Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Parkinson’s Disease Treatment market by identifying its various subsegments.

Focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Parkinson’s Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Parkinson’s Disease Treatment submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Parkinson’s Disease Treatment Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Parkinson’s Disease Treatment Market Size 2014-2024

2.1.2 Parkinson’s Disease Treatment Market Size CAGR by Region

2.2 Parkinson’s Disease Treatment Segment by Type

2.2.1 Oral

2.2.2 Oral

2.2.3 Subcutaneous

2.2.4 Intestinal Infusion

2.3 Parkinson’s Disease Treatment Market Size by Type

2.3.1 Global Parkinson’s Disease Treatment Market Size Market Share by Type (2014-2019)

2.3.2 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (2014-2019)

2.4 Parkinson’s Disease Treatment Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 Online Pharmacy

2.5 Parkinson’s Disease Treatment Market Size by Application

2.5.1 Global Parkinson’s Disease Treatment Market Size Market Share by Application (2014-2019)

2.5.2 Global Parkinson’s Disease Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Parkinson’s Disease Treatment by Players

3.1 Global Parkinson’s Disease Treatment Market Size Market Share by Players

3.1.1 Global Parkinson’s Disease Treatment Market Size by Players (2017-2019)

3.1.2 Global Parkinson’s Disease Treatment Market Size Market Share by Players (2017-2019)

3.2 Global Parkinson’s Disease Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Parkinson’s Disease Treatment by Regions

4.1 Parkinson’s Disease Treatment Market Size by Regions

4.2 Americas Parkinson’s Disease Treatment Market Size Growth

4.3 APAC Parkinson’s Disease Treatment Market Size Growth

4.4 Europe Parkinson’s Disease Treatment Market Size Growth

4.5 Middle East & Africa Parkinson’s Disease Treatment Market Size Growth

5 Americas

5.1 Americas Parkinson’s Disease Treatment Market Size by Countries

5.2 Americas Parkinson’s Disease Treatment Market Size by Type

5.3 Americas Parkinson’s Disease Treatment Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Parkinson’s Disease Treatment Market Size by Countries

6.2 APAC Parkinson’s Disease Treatment Market Size by Type

6.3 APAC Parkinson’s Disease Treatment Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Parkinson’s Disease Treatment by Countries

7.2 Europe Parkinson’s Disease Treatment Market Size by Type

7.3 Europe Parkinson’s Disease Treatment Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Parkinson’s Disease Treatment by Countries

8.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type

8.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Parkinson’s Disease Treatment Market Forecast

10.1 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)

10.2 Global Parkinson’s Disease Treatment Forecast by Regions

10.2.1 Global Parkinson’s Disease Treatment Forecast by Regions (2019-2024)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Parkinson’s Disease Treatment Forecast by Type

10.8 Global Parkinson’s Disease Treatment Forecast by Application

11 Key Players Analysis

11.1 Acorda Therapeutics

11.1.1 Company Details

11.1.2 Parkinson’s Disease Treatment Product Offered

11.1.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.1.4 Main Business Overview

11.1.5 Acorda Therapeutics News

11.2 Orion Pharmaceuticals

11.2.1 Company Details

11.2.2 Parkinson’s Disease Treatment Product Offered

11.2.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.2.4 Main Business Overview

11.2.5 Orion Pharmaceuticals News

11.3 Roche

11.3.1 Company Details

11.3.2 Parkinson’s Disease Treatment Product Offered

11.3.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.3.4 Main Business Overview

11.3.5 Roche News

11.4 Teva

11.4.1 Company Details

11.4.2 Parkinson’s Disease Treatment Product Offered

11.4.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.4.4 Main Business Overview

11.4.5 Teva News

11.5 Voyager Therapeutics

11.5.1 Company Details

11.5.2 Parkinson’s Disease Treatment Product Offered

11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.5.4 Main Business Overview

11.5.5 Voyager Therapeutics News

11.6 Prothena

11.6.1 Company Details

11.6.2 Parkinson’s Disease Treatment Product Offered

11.6.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.6.4 Main Business Overview

11.6.5 Prothena News

11.7 AbbVie

11.7.1 Company Details

11.7.2 Parkinson’s Disease Treatment Product Offered

11.7.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.7.4 Main Business Overview

11.7.5 AbbVie News

11.8 Impax Pharmaceuticals

11.8.1 Company Details

11.8.2 Parkinson’s Disease Treatment Product Offered

11.8.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.8.4 Main Business Overview

11.8.5 Impax Pharmaceuticals News

11.9 MSD

11.9.1 Company Details

11.9.2 Parkinson’s Disease Treatment Product Offered

11.9.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.9.4 Main Business Overview

11.9.5 MSD News

11.10 UCB

11.10.1 Company Details

11.10.2 Parkinson’s Disease Treatment Product Offered

11.10.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)

11.10.4 Main Business Overview

11.10.5 UCB News

11.11 GSK

11.12 Intec Pharma

11.13 Acadia

11.14 Adamas Therapeutics

11.15 Sunovion

11.16 NeuroDerm

12 Research Findings and Conclusion

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.